POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,460,199 | -26.4% | 10,563,748 | 0.0% | 1.90% | -28.8% |
| Q2 2023 | $95,707,557 | +24.6% | 10,563,748 | 0.0% | 2.67% | -5.0% |
| Q1 2023 | $76,798,448 | +14.8% | 10,563,748 | +15.1% | 2.81% | -0.6% |
| Q4 2022 | $66,905,783 | +54.8% | 9,177,748 | +64.2% | 2.82% | +58.2% |
| Q3 2022 | $43,211,000 | +88.4% | 5,590,048 | +66.0% | 1.78% | +61.1% |
| Q2 2022 | $22,935,000 | -14.6% | 3,367,826 | 0.0% | 1.11% | +3.2% |
| Q1 2022 | $26,842,000 | +64.1% | 3,367,826 | +15.3% | 1.07% | +80.8% |
| Q4 2021 | $16,355,000 | -23.3% | 2,920,526 | +5.3% | 0.59% | -28.6% |
| Q3 2021 | $21,318,000 | – | 2,772,226 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,909,960 | $19,409,433 | 3.54% |
| JOHNSON & JOHNSON | 1,000,000 | $6,670,000 | 2.46% |
| BVF INC/IL | 10,563,748 | $70,460,199 | 1.90% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,354,122 | 1.16% |
| Boxer Capital, LLC | 2,500,000 | $16,675,000 | 0.89% |
| Pier Capital, LLC | 732,936 | $4,888,683 | 0.79% |
| Deep Track Capital, LP | 2,781,565 | $18,553,039 | 0.72% |
| PFM Health Sciences, LP | 1,613,516 | $10,762,152 | 0.51% |
| Eagle Health Investments LP | 306,142 | $2,041,967 | 0.45% |
| Onex Canada Asset Management Inc. | 772,905 | $5,155,276 | 0.40% |